RECRUITING

Droperidol and QTc Interval Changes in ED Patients

Description

Objectives To assess the association of low-dose Droperidol administration in the emergency department with changes in the QTc interval. Hypothesis Our study is designed to test the null hypothesis that there will be no clinically significant change in QTc interval after administration of 2.5mg of IV Droperidol during an emergency department visit.

Conditions

Emergency Department PatientQTc Intervals Changes
Talk to us

Related Conditions:

Emergency Department PatientQTc Intervals Changes

Study Overview

On this page

Study Details

Study overview

Objectives To assess the association of low-dose Droperidol administration in the emergency department with changes in the QTc interval. Hypothesis Our study is designed to test the null hypothesis that there will be no clinically significant change in QTc interval after administration of 2.5mg of IV Droperidol during an emergency department visit.

Low-Dose Droperidol and Its Association with QTc Interval Changes in Emergency Department Patients

Droperidol and QTc Interval Changes in ED Patients

Condition
Emergency Department Patient
Intervention / Treatment

-

Contacts and Locations

Corpus Christi

CHRISTUS Spohn Hospital Corpus Christi-Shoreline, Corpus Christi, Texas, United States, 78405

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * ED patients ages 18 years or older in a cardiovascular-monitored bed who have both an ECG and a 2.5 mg dose of IV droperidol ordered by their treating physician will be eligible for inclusion.
  • * Refusal to provide consent.
  • * Administration of droperidol before the first ECG is performed.
  • * Inability to complete the consent form and questionnaire due to clinical instability, severe pain, or disorientation as determined by a study physician.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

CHRISTUS Health,

Study Record Dates

2026-09-30